Jove
Visualize
Contact Us

Related Experiment Videos

Discriminating different classes of toxicants by transcript profiling.

Guido Steiner1, Laura Suter, Franziska Boess

  • 1Non-Clinical Drug Safety, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Environmental Health Perspectives
|September 4, 2004
PubMed
Summary

Gene expression profiles in rats can classify compounds as toxic or non-toxic. This approach accurately identifies hepatotoxicants and works across different rat strains, confirming gene expression

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Clinical pharmacology and therapeutics·2026
Same author

Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Discovery of Potent and Efficacious Influenza PB2 Inhibitors.

ACS medicinal chemistry letters·2026
Same author

RO4938581, a GABA<sub>A</sub>-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome.

Molecular psychiatry·2026
Same author

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.

Cancer research·2025
Same author

Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release.

Molecular therapy. Methods & clinical development·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Toxicology
  • Genomics
  • Bioinformatics

Background:

  • Hepatotoxicity assessment is crucial in preclinical drug development.
  • Traditional methods like histopathology can be time-consuming and subjective.
  • Gene expression profiling offers a high-throughput approach to understand compound effects.

Purpose of the Study:

  • To determine if gene expression profiles can classify compounds based on toxicity.
  • To identify potential gene expression biomarkers for hepatotoxicity.
  • To assess the feasibility of using machine learning for toxicity classification.

Main Methods:

  • Male rats were treated with various compounds or vehicle controls.
  • Hepatic gene expression was analyzed using microarrays.

Related Experiment Videos

  • Supervised learning (Support Vector Machines; SVMs) with recursive feature elimination was employed for classification and biomarker identification.
  • Serum chemistry and histopathology were used for validation.

    • Main Results:

    • Predictive models successfully discriminated between hepatotoxic and non-hepatotoxic compounds.
    • Models accurately classified the type of hepatotoxicant in most cases.
    • A predictive model trained on one rat strain successfully classified profiles from another strain.
    • The models identified non-responders and differentiated between pharmacological and toxic effects.

    Conclusions:

    • Compound classification based on gene expression data is feasible and accurate.
    • Gene expression profiling, combined with machine learning, is a powerful tool for toxicity assessment.
    • This approach can accelerate preclinical safety evaluations and biomarker discovery.